![](/img/cover-not-exists.png)
P-58 Phase II study of irinotecan/cisplatin (IP) induction chemotherapy followed by concurrent twice-daily thoracic radiotherapy (RT) with etoposide/cisplatin (EP) for limited disease small cell lung cancer (LD-SCLC)
Han, Ji-Youn, Cho, Kwan Ho, Lee, Dae Ho, Yoon, Seong Min, Kim, Hyae Young, Lee, Sung Young, Yoo, Han Jin, Lee, Jin SooVolume:
41
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/s0169-5002(03)92027-7
Date:
August, 2003
File:
PDF, 176 KB
english, 2003